Prognostic Significance of Increased Bone Marrow Microcirculation in Newly Diagnosed Multiple Myeloma: Results of a Prospective DCE-MRI Study
Overview
Authors
Affiliations
Objectives: Aim of this prospective study was to investigate prognostic significance of increased bone marrow microcirculation as detected by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for survival and local complications in patients with multiple myeloma (MM).
Methods: We performed DCE-MRI of the lumbar spine in 131 patients with newly diagnosed MM and analysed data according to the Brix model to acquire amplitude A and exchange rate constant kep. In 61 patients a second MRI performed after therapy was evaluated to assess changes in vertebral height and identify vertebral fractures.
Results: Correlation analysis revealed significant positive association between beta2-microglobulin as well as immunoparesis with DCE-MRI parameters A and kep. Additionally, A was negatively correlated with haemoglobin levels and kep was positively correlated with LDH levels. Higher baseline kep values were associated with decreased vertebral height in a second MRI (P = 0.007) and A values were associated with new vertebral fractures in the lower lumbar spine (P = 0.03 for L4). Pre-existing lytic bone lesions or remission after therapy had no impact on the occurrence of vertebral fractures. Multivariate analysis revealed that amplitude A is an independent adverse risk factor for overall survival.
Conclusion: DCE-MRI is a non-invasive tool with significance for systemic prognosis and vertebral complications.
Key Points: • Qualitative parameters from DCE-MRI are correlated with established factors of disease activity • Increased marrow microcirculation might be a risk factor for loss of vertebral height and fractures • Amplitude A is an independent predictor for shortened overall survival.
Jamet B, Necib H, Carlier T, Frampas E, Bazin J, Desfontis P Cancer Imaging. 2024; 24(1):93.
PMID: 38992707 PMC: 11241781. DOI: 10.1186/s40644-024-00740-5.
Ojha V, Bahl V, Ramachandra S, Prashant A Cureus. 2022; 13(12):e20788.
PMID: 35141056 PMC: 8796275. DOI: 10.7759/cureus.20788.
Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography.
Oprea-Lager D, Cysouw M, Boellaard R, Deroose C, de Geus-Oei L, Lopci E Front Oncol. 2021; 11:772530.
PMID: 34869009 PMC: 8640187. DOI: 10.3389/fonc.2021.772530.
Functional and molecular MRI of the bone marrow in multiple myeloma.
Koutoulidis V, Papanikolaou N, Moulopoulos L Br J Radiol. 2018; 91(1088):20170389.
PMID: 29393672 PMC: 6209491. DOI: 10.1259/bjr.20170389.
Latifoltojar A, Hall-Craggs M, Bainbridge A, Rabin N, Popat R, Rismani A Eur Radiol. 2017; 27(12):5325-5336.
PMID: 28656463 PMC: 5674123. DOI: 10.1007/s00330-017-4907-8.